Skip to content

The effects of coconut oil in metabolic syndrome

To assess the effects of coconut oil consumption on metabolic syndrome indices in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131125015536N11
Enrollment
44
Registered
2020-01-10
Start date
2019-07-22
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome. metabolic syndrome

Interventions

Intervention 1: Intervention group: Daily intake of 30 ml of coconut oil in the preparation of food or cold as an alternative to the portion of the oil intake. Intervention 2: Control group: People in

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 20 to 50 years old men and women diagnosed as metabolic syndrome Giving informed consent for participation in the study

Exclusion criteria

Exclusion criteria: The history of any type of medical or surgical disease, drinking alcohol, history of coconut oil intolerance, pregnancy or breastfeeding, smoking or any type of drug, the use of any drug or supplement that affects metabolic syndrome indices. , Compliance with a particular diet or weight loss program, changes in the last three months and professional exercise, a patient's unwillingness to continue to study, hypersensitivity or intolerance to the consumption of coconut oil

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Digital barometer.;Serum Fasting blood glucose level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum triglyceride level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum HDL-C level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum Asymmetric D-methyl arginine level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Eliza kit.;Waist circumference. Timepoint: Before and after 4 weeks of intervention. Method of measurement: observation.;Serum brain derived neurotrophic factor level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Eliza kit.

Secondary

MeasureTime frame
Body composition analysis. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Bio-electrical impedance analysis.;Serum lipid profile. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Enzymatic Kit.;Serum insulin level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Eliza kit.;Serum malondialdehyde level. Timepoint: Before and after 4 weeks of intervention. Method of measurement: MDA assay Kit (colorimetrically or fluorometrically).;Serum total antioxidant capacity. Timepoint: Before and after 4 weeks of intervention. Method of measurement: TAC assay Kit (photometrically).

Countries

Iran (Islamic Republic of)

Contacts

Public Contactparinaz nikooei

Tehran University of Medical Sciences

parinaznikooei@gmail.com+98 21 8895 5975

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 25, 2026